T/FIF Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (322)	12/23/1998 10:01:00 AM
From: scaram(o)uche	Read Replies (1) of 1073

>> Does this new technology license from Scripts suggest/indicate path by which they intend to solve problem with allogenic steam cells implant(immunology and differentiation/factor)? << Hard to tell, as the release was (1) poorly written, and (2) full of "somedays", "maybes", and "we are praying thats". :-) I think that this may be the transgenic strains that were referred to....... ncbi.nlm.nih.gov Dr. Sarvetnick is crawling all over diabetes and the regulation of T cell responses, so it's not an issue that it's a big plus to have her on the CTII team.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next